Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
Getinge has a strong market share in India within several product segments
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The award recognizes and supports promising female scientists working in mass spectrometry
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Subscribe To Our Newsletter & Stay Updated